$10.93
1.18%
Nasdaq, Jul 03, 07:00 pm CET
ISIN
US05463X1063
Symbol
AXGN

AxoGen, Inc. Stock price

$10.93
-0.43 3.79% 1M
-5.18 32.15% 6M
-5.55 33.68% YTD
+3.27 42.69% 1Y
+2.76 33.78% 3Y
-0.56 4.87% 5Y
+7.75 243.71% 10Y
+9.67 765.88% 20Y
Nasdaq, Closing price Thu, Jul 03 2025
-0.13 1.18%
ISIN
US05463X1063
Symbol
AXGN
Sector

Key metrics

Basic
Market capitalization
$497.8m
Enterprise Value
$523.5m
Net debt
$25.7m
Cash
$22.1m
Shares outstanding
45.5m
Valuation (TTM | estimate)
P/E
negative | 51.4
P/S
2.6 | 2.3
EV/Sales
2.7 | 2.4
EV/FCF
negative
P/B
4.7
Dividends
DPS
-
Yield 1Y | 5Y
- | -
Growth 1Y | 5Y
- | -
Payout 1Y | 3Y
- | -
Increased
-
Financials (TTM | estimate)
Revenue
$194.5m | $221.2m
EBITDA
$7.4m | $28.0m
EBIT
$-388.0k | $2.8m
Net Income
$-7.2m | $9.7m
Free Cash Flow
$-220.0k
Growth (TTM | estimate)
Revenue
18.8% | 18.1%
EBITDA
156.8% | 516.3%
EBIT
97.9%
Net Income
66.4% | 197.1%
Free Cash Flow
99.0%
Margin (TTM | estimate)
Gross
74.2%
EBITDA
3.8% | 12.7%
EBIT
-0.2%
Net
-3.7% | 4.4%
Free Cash Flow
-0.1%
Financial Health
Equity Ratio
51.0%
Return on Equity
-9.6%
ROCE
-0.2%
ROIC
-
Debt/Equity
0.5
More
EPS
$-0.2
FCF per Share
$0.0
Short interest
5.1%
Employees
452
Rev per Employee
$410.0k
Show more

Is AxoGen, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,967 stocks worldwide.

AxoGen, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a AxoGen, Inc. forecast:

13x Buy
93%
1x Hold
7%

Analyst Opinions

14 Analysts have issued a AxoGen, Inc. forecast:

Buy
93%
Hold
7%

Financial data from AxoGen, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
195 195
19% 19%
100%
- Direct Costs 50 50
42% 42%
26%
144 144
12% 12%
74%
- Selling and Administrative Expenses 118 118
0% 0%
61%
- Research and Development Expense 26 26
9% 9%
14%
7.43 7.43
157% 157%
4%
- Depreciation and Amortization 7.82 7.82
39% 39%
4%
EBIT (Operating Income) EBIT -0.39 -0.39
98% 98%
0%
Net Profit -7.16 -7.16
66% 66%
-4%

In millions USD.

Don't miss a Thing! We will send you all news about AxoGen, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

AxoGen, Inc. Stock News

Neutral
GlobeNewsWire
about one month ago
ALACHUA, Fla. and TAMPA, Fla., May 28, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Michael Dale, board director, chief executive officer, and president, will participate in a fireside chat at the Goldman Sachs Global Healthcare Conference, on Wednesday, June 11...
Neutral
Seeking Alpha
about 2 months ago
Axogen, Inc. (AXGN) Q1 2025 Earnings Call Transcript
Neutral
GlobeNewsWire
about 2 months ago
ALACHUA, Fla. and TAMPA, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results and business highlights for the first quarter ended March 31, 2025.
More AxoGen, Inc. News

Company Profile

AxoGen, Inc. engages in the development and market of surgical solutions for peripheral nerves. It also provides products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. Its products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator. The company was founded in 1977 and is headquartered in Alachua, FL.

Head office United States
CEO Michael Dale
Employees 452
Founded 1977
Website www.axogeninc.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today